Home/Filings/4/0001225208-21-010280
4//SEC Filing

WICHMANN DAVID S 4

Accession 0001225208-21-010280

CIK 0000885725other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:12 PM ET

Size

8.9 KB

Accession

0001225208-21-010280

Insider Transaction Report

Form 4
Period: 2021-07-01
Transactions
  • Award

    Deferred Stock Units

    2021-07-01+4,0934,093 total
    Common Stock (4,093 underlying)
  • Award

    Deferred Stock Units

    2021-07-01+2,2966,389 total
    Common Stock (2,296 underlying)
Footnotes (5)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Reflects a value of approximately $177,500 (representing the prorated amount of the non-employee director compensation program's annual equity grant having a value of $205,000) divided by the closing price of common stock on the date of grant.
  • [F3]Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2022 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
  • [F4]Reflects a value of approximately $99,600 (representing the prorated amount of the non-employee director compensation program's cash retainer having a value of $115,000) divided by the closing price of the common stock on the date of grant.
  • [F5]Grant of deferred stock units in lieu of yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2022 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001268489

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:12 PM ET
Size
8.9 KB